Remove Hemorrhage Remove Risk Factors Remove Thrombolysis
article thumbnail

Abstract TP20: Intravenous thrombolysis versus early antiplatelet therapy in acute Ischemic Stroke with Small Artery Occlusion

Stroke Journal

Patients with elevated traditional risk factors at admission may benefit more from thrombolytic therapy compared to those with high inflammatory response indicators. Stroke, Volume 56, Issue Suppl_1 , Page ATP20-ATP20, February 1, 2025. The primary outcome was 3-month functional outcome by modified Rankin scale (mRS).

article thumbnail

Abstract WP21: Intravenous Alteplase for Unknown Onset Stroke on Prior Antiplatelet Therapy: EOS Individual Participant Data

Stroke Journal

Introduction:Although prior antiplatelet therapy (APT) could potentially contribute to bleeding risk, the influence of prior APT on intravenous thrombolysis outcomes remains controversial. Patients with prior APT were older (72 vs. 66 years), and had a higher prevalence of vascular risk factors than those without APT.

Stroke 40
article thumbnail

Abstract WP5: Outcomes of Pre-Stroke Use of Metformin in Acute Ischemic Stroke Patients With Diabetes Mellitus: A Systematic Review and Meta-Analysis

Stroke Journal

Background:Diabetes mellitus (DM) is one of the risk factors for acute ischemic stroke, usually leading to poor prognosis. While DM can reduce the effect of intravenous thrombolysis, metformin can have a positive outcome on AIS patients. Stroke, Volume 55, Issue Suppl_1 , Page AWP5-AWP5, February 1, 2024.

article thumbnail

Abstract 229: Recanalization Rate in Mechanical Thrombectomy in Patients With Elevated LDL?C Levels

Stroke: Vascular and Interventional Neurology

IntroductionA high level of low‐density lipoprotein ‐ cholesterol (LDL‐C) is a known risk factor for ischemic stroke1. We collected data on baseline characteristics and demographics, functional outcomes at discharge and 90 days, and procedural information including final thrombolysis in cerebral infarction (TICI) grade.

article thumbnail

Abstract WP24: Symptomatic hemorrhage after thrombolysis: results from the Alteplase compared to Tenecteplase in patients with acute ischemic stroke trial

Stroke Journal

Introduction:Because of the risk of infarcted tissue leading to symptomatic intracerebral hemorrhage (sICH) after intravenous thrombolysis for acute ischemic stroke, patients are monitored for at least 24 hours in a critical care setting.

article thumbnail

SHINE Trial Sheds Light on Deadly Stroke Complication

DAIC

The new analysis of the trial results, led by UVA Health’s Andrew Southerland , MD, found that high blood sugar shortly after thrombolysis – opening blocked arteries in the brain with a clot-busting drug – was associated with greater risk for potentially deadly brain bleeds, particularly in older patients with more severe strokes.

Stroke 105
article thumbnail

World Stroke Day: Understanding and Combating the "Silent Killer"

ADN Center of Excellence

The Impact of Stroke on Global Health A stroke occurs when blood flow to a part of the brain is interrupted, either by a clot (ischemic stroke) or a ruptured vessel (hemorrhagic stroke). With machine learning algorithms analyzing brain scans, healthcare providers can identify high-risk patients sooner, allowing for proactive measures.

Stroke 59